These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 28052033)
1. GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer. Yang J; Wen J; Tian T; Lu Z; Wang Y; Wang Z; Wang X; Yang Y Oncotarget; 2017 Feb; 8(7):11788-11796. PubMed ID: 28052033 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients. Sharen G; Peng Y; Cheng H; Liu Y; Shi Y; Zhao J Oncotarget; 2017 Mar; 8(12):19760-19767. PubMed ID: 28178665 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis. Li CX; Sun JL; Gong ZC; Lin ZQ; Liu H Medicine (Baltimore); 2016 Nov; 95(45):e5324. PubMed ID: 27828852 [TBL] [Abstract][Full Text] [Related]
4. Potential Role of Glucose Transporter-1 Expression in Gastric Cancer: A Meta-Analysis and Systematic Review. Tao J; Zhang Y; Wang T Iran J Public Health; 2020 Nov; 49(11):2044-2053. PubMed ID: 33708725 [TBL] [Abstract][Full Text] [Related]
5. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis. Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis. Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis. Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090 [TBL] [Abstract][Full Text] [Related]
9. High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database. Du L; Li J; Lei L; He H; Chen E; Dong J; Yang J Biomed Res Int; 2018; 2018():6387810. PubMed ID: 29955607 [TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis. Zhou N; Gu Q Medicine (Baltimore); 2018 Mar; 97(12):e0195. PubMed ID: 29561443 [TBL] [Abstract][Full Text] [Related]
11. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis. Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942 [TBL] [Abstract][Full Text] [Related]
12. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis. Ye D; Jiang D; Li Y; Jin M; Chen K Int J Clin Oncol; 2017 Aug; 22(4):749-757. PubMed ID: 28343299 [TBL] [Abstract][Full Text] [Related]
13. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis. Wu SW; Ma CC; Li WH Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145 [TBL] [Abstract][Full Text] [Related]
14. A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor. Calik I; Calik M; Turken G; Ozercan IH Int J Clin Exp Pathol; 2020; 13(2):107-121. PubMed ID: 32211091 [TBL] [Abstract][Full Text] [Related]
15. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis. Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z BMC Cancer; 2015 Dec; 15():948. PubMed ID: 26674601 [TBL] [Abstract][Full Text] [Related]
16. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies. Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961 [TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis. Zhang B; Xie Z; Li B Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981 [TBL] [Abstract][Full Text] [Related]
18. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis. Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958 [TBL] [Abstract][Full Text] [Related]
19. Does adjuvant chemotherapy improve the prognosis of patients after resection of pulmonary metastasis from colorectal cancer? A systematic review and meta-analysis. Zhang C; Tan Y; Xu H Int J Colorectal Dis; 2019 Oct; 34(10):1661-1671. PubMed ID: 31446479 [TBL] [Abstract][Full Text] [Related]
20. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis. Zhao M; Liang F; Zhang B; Yan W; Zhang J Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]